biocryst is terminating bcx5191 program, page-23

"Why did Biota made a contrarian investment? If big pharmas did not love antibiotics programs, then what took Biota to love it? "

-----

Simple. They were cheap and they had potential.

I will go back to the Clive Palmer and Nathan Tinkler example. Why did these small players (at the time) buy coal leases?

Because they were at the bottom of the cycle and because they saw potential.

Don't fault the board buying theses assets. Fault them for returning the $20m...that would have gone some way to accelerating LANI ROW.